ZABDENO

Live / Allowed — Fifth extension granted (statement of use) (as of 07 Aug 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Dec 2022 filing date already counts against anyone who files later.

Record

Serial number
97706853
Mark type
Word mark
Filed
07 Dec 2022
Published for opposition
26 Sept 2023
Attorney of record
Cheryl L. Foytlin

Goods and services

  • Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Owner

Prosecution history

  • 07 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 Aug 2026 — SOU EXTENSION 5 GRANTED
  • 20 Apr 2026 — SOU EXTENSION 5 FILED
  • 07 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
  • 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 Oct 2025 — SOU EXTENSION 4 GRANTED
  • 07 Oct 2025 — SOU EXTENSION 4 FILED
  • 07 Oct 2025 — SOU TEAS EXTENSION RECEIVED
  • 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 01 May 2025 — SOU EXTENSION 3 GRANTED
  • 01 May 2025 — SOU EXTENSION 3 FILED
  • 01 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 28 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 Oct 2024 — SOU EXTENSION 2 GRANTED

View this trademark record on Rightsy